Simvastatin administered during the first week of IS inhibited the serum MMP-9 activity, although the early treatment with simvastatin (started at first day after stroke onset) influenced neither MMP-9 nor TIMP-1 levels [167]. This evidence concerns the gene MMP9 and stroke disorder.